4//SEC Filing
Eagle Holding Co I 4
Accession 0001104659-18-048806
CIK 0001330436other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:12 PM ET
Size
17.0 KB
Accession
0001104659-18-048806
Insider Transaction Report
Form 4
Jaguar Holding Co II
10% Owner
Transactions
- Conversion
Common stock
2018-07-30+442,819→ 442,819 total - Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying)
Transactions
- Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying) - Conversion
Common stock
2018-07-30+442,819→ 442,819 total
Eagle Holding Co II, LLC
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying) - Conversion
Common stock
2018-07-30+442,819→ 442,819 total
Transactions
- Conversion
Common stock
2018-07-30+442,819→ 442,819 total - Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying)
Eagle Holding Co I
10% Owner
Transactions
- Conversion
Common stock
2018-07-30+442,819→ 442,819 total - Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying)
Jaguar Holding Co I, LLC
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2018-07-30−3,420,516→ 0 total→ Common Stock (442,819 underlying) - Conversion
Common stock
2018-07-30+442,819→ 442,819 total
Footnotes (3)
- [F1]The Series C Preferred Stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- [F2]These securities are held of record by Pharmaceutical Product Development, LLC ("Pharma LLC"). Wildcat Acquisition Holdings (UK) Limited ("Wildcat") is the sole member of Pharma LLC; Jaguar Holding Company II ("Jaguar II") is the sole shareholder of Wildcat; Jaguar Holding Company I, LLC ("Jaguar I") is the sole shareholder of Jaguar II; Eagle Holding Company II, LLC ("Eagle II") is the sole member of Jaguar I; and Eagle Holding Company I is the sole member of Eagle II. By virtue of such relationships, each of the reporting persons may be deemed to have beneficial ownership over such securities.
- [F3]This report on Form 4 is jointly filed by the reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Documents
Issuer
Liquidia Technologies Inc
CIK 0001330436
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001705719
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:12 PM ET
- Size
- 17.0 KB